BRIEF-Intellipharmaceutics U.S.-listed shares up 93.1 percent premarket

Tue Nov 19, 2013 7:39am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

NEW YORK Nov 19 (Reuters) - Intellipharmaceutics International Inc : * U.S.-listed shares up 93.1 percent to $3.65 in premarket; gets final FDA OK to commercially launch 15 and 30 mg generic Focalin XR